Target genes for the helicase-like transcription factor (HLTF), a member of the SNF/SWI family, were immunoprecipitated from HeLa chromatin fragments with an anti-HLTF antibody. A 182 bp fragment (HEFT1) presented 87% sequence identity with 3.3 kb dispersed repeats from the 4q35 D4Z4 locus linked to facioscapulohumeral muscular dystrophy (FSHD). The HEFT1 loci were, however, not genetically linked to FSHD. Transfection and in vitro binding studies identified within HEFT1 a promoter whose basal activity required a GC box activated by Sp1 or Sp3. A 4.4 kb homologous transcript was found mostly in human skeletal muscle and heart. A 1.2 kb cDNA fragment was cloned that encoded a 170 amino acid protein (DUX1) with two paired-type homeodomains. In vitro translated DUX1 specifically interacted in electrophoretic mobility shift assay (EMSA) with a P5 oligonucleotide (5′-GATCTGAGTCTAATTGAGAATTACTGTAC-3′). 
INTRODUCTION
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder, characterized by progressive weakening of the muscles of the face, shoulders and upper arms, that maps close to a telomere of human chromosome 4 (4q35) (1) . A polymorphic 3.3 kb tandem repeat locus (D4Z4) that is tightly linked to FSHD has been cloned and characterized: deletions of integral repeat numbers have been associated with the disease (2, 3) and the phenotype severity correlated with the size of the deletion (4) . Although no transcribed gene could be identified in the locus, a double homeobox is present in each of the two sequenced repeats (5, 6) and is conserved in primates (7), leading to the hypothesis that the FSHD gene might be contained in the repeats and that a deletion might alter its expression (reviewed in ref. 8 ). Identification of a putative mRNA derived from this locus is complicated by the fact that the 3.3 kb elements present in D4Z4 are members of a dispersed family with clusters of tandem repeats on several chromosomes (9) . Another hypothesis about the origin of the disease holds that D4Z4 repeats constitute a heterochromatic region 'buffering' the expression of a hitherto unidentified gene from silencing by the nearby telomere: deletions leaving eight or less repeats would allow silencing of that gene and cause FSHD (10) . Such a candidate gene was recently identified, but no difference in expression pattern between patients and controls was shown (11) .
In a different research domain, we have recently isolated the helicase-like transcription factor (HLTF), which is involved in basal expression of the human gene encoding plasminogen activator inhibitor-1 (PAI-1), presents homology to proteins of the SNF/SWI family and has a specific DNA-binding domain, a RING finger domain and seven conserved DNA helicase domains (12) . It was cloned independently by others because it binds to the HIV long terminal repeat (13) and to the myosin light chain enhancer (14) and was shown to display DNA-dependent ATPase activity (13, 14) . The DNA sequence specifically recognized by this protein, as defined by a target definition assay, is rather degenerate (data not shown), suggesting that many genes could be targets of HLTF. In the present study, initiated to identify such genes, a monoclonal antibody (mAb 2F6) against the DNA-binding domain of HLTF (12) was used to immunoprecipitate genomic DNA fragments binding HLTF. One of the isolated fragments, named HEFT1 (helicase-like transcription factor target 1), presented a consensus TATAA box, suggesting a promoter activity. In addition, although mapping to different chromosomal loci and thus certainly not linked to the disease, HEFT1 showed high similarity to 3.3 kb repeated elements derived from the D4Z4 locus linked to FSHD. The HEFT1 fragment was further characterized and a homologous cDNA found that encoded a new transcription factor with two homeodomains. Alignment of both sequences identified similar promoter and open reading frame (ORF) features in FSHD locus repeats.
RESULTS

Isolation of genomic DNA fragments bound by HLTF
Nuclei from HeLa cells were digested with HaeIII and the HLTF-DNA complexes immunoprecipitated from the resulting chromatin fragments (15) with an anti-HLTF monoclonal antibody (mAb 2F6) that was previously shown not to prevent specific interaction between HLTF and DNA (12) . The isolated genomic fragments were cloned and screened by electrophoretic mobility shift assay (EMSA) for binding to bacterially produced GST-6D3, containing the DNA-binding domain of HLTF (12) . Of the 168 clones screened, 61 were positive and their nucleotide sequences were determined; 20 of these were repetitive elements, such as Alu sequences, long interspersed elements (LINEs) and α-satellites, that were not further investigated.
One clone, named HEFT1, contained two HLTF binding sites as determined by EMSA (data not shown): its nucleotide sequence was determined, showing a putative TATAA box (Fig.  1A) . A computer search in the GenBank and EMBL databases with the FASTA program disclosed that HEFT1 had 87% nucleotide identity to a low copy human repeat designated hhspm3 (16) and 82-86% nucleotide sequence identity to parts of the tandem repeat locus D4Z4 associated with FSHD (5, 6, 9) . HEFT1 is also 87% similar to two cDNA clones related to D4Z4 but expressed from other loci: cDNAJH and cDNAδ4 (5) . A summary of the published sequences homologous to HEFT1 is provided in Table 1 .
The HEFT1 loci were mapped to chromosomes 13, 14, 15, 21 and 22 by 'touchdown' PCR (17) on genomic DNA from a panel of hamster/human hybrids with primers presenting at least one mismatch with the known homologous sequences, followed by a Southern blot of these PCR products hybridized at high stringency with an internal HEFT1 primer (see Materials and Methods). Specificity of the PCR reactions was confirmed by using as templates representatives of several known 3.3 kb elements (Table 1) , i.e. cDNAs TFB1 2A and δ4 and genomic DNA XPst9 from the FSHD locus (data not shown).
In summary, HEFT1 is a new member of the 3.3 kb element family with high similarity to 3.3 kb repeats, but does not map to the FSHD locus.
Promoter activity of the isolated HEFT1 fragment
The 182 bp HEFT1 fragment was inserted upstream from a luciferase (luc) reporter gene and the construct was introduced into HeLa cells. Transient HEFT1-luc expression led to a 250-fold induction of luciferase activity as compared with the promoterless luc vector (pGL3-Basic), a higher activity than the SV40 promoter used as a positive control ( Fig. 2A) . Transfection of human rhabdomyosarcoma TE671 cells led to a 110-fold induction of transient HEFT1-luc expression (data not shown).
In order to locate the transcription initiation site within HEFT1, mRNAs were isolated from HeLa cells transfected with HEFT1-luc and used as templates in a primer extension experiment using a primer complementary to a portion of the luc gene. One major extension product was observed (Fig. 2B ) corresponding to the G located 23 bp 3′ of the TATAA box, hence numbered +1 in the sequence (Fig. 1A) . The two point mutations (Gmut) were introduced into the -60 HEFT1-luc construct, affecting G3 or G4 of the Sp1 binding site described in (A). (C) Proteins binding in vitro to the basal element of the HEFT1 promoter. EMSA was performed with 10 µg nuclear extract from HeLa cells and 2 × 10 4 c.p.m. 32 P-end-labelled double-stranded oligonucleotides (HEFT1 coordinates -60 to -36), corresponding either to the Sp1 binding site (lanes 1, 2 and 7-10) or its two point mutants, G3mut (lanes 3 and 4) and G4mut (lanes 5 and 6). Antibodies (100 ng) directed against either HLTF (mAb 2F6, lanes 2, 4 and 6), Sp1 (lanes 8 and 10) or Sp3 (lanes 9 and 10) were added as indicated. Three protein-DNA complexes (C1, C2 and C3), the supershifted complex (S) and free DNA (F) are indicated. (D) Trans-activation of HEFT1 by transient expression of Sp1 and Sp3. Drosophila SL2 cells were co-transfected with 4 µg HEFT1-lacZ vectors containing either the wild-type HEFT1 promoter (lanes 1-3), the -60 HEFT1 deletion mutant (lanes 4-6) or the G3mut (lanes 7-9) or G4mut (lanes 10-12) point mutants and with 1 µg pPacUbx expression vector containing either no insert (open bars) or the cDNAs encoding Sp1 (lanes 2, 5, 8 and 11) or Sp3 (lanes 3, 6, 9 and 12). β-Galactosidase activities were determined 24 h after transfection. Data are provided as means ± SD of three different experiments performed in triplicate. Details are described in Materials and Methods.
Trans-activation of the HEFT1 minimal promoter by Sp1 and Sp3
Several putative binding sites for transcription factors were found by sequence analysis of the HEFT1 sequence (18) : in order to identify the functional ones, a set of progressive 5′ deletions (end points indicated in Fig. 1A) were introduced into the HEFT1-luc fusion gene. Removal of sequences from -117 to -60 bp did not alter luc transient expression in transfected HeLa cells, whereas further deletion to -49 bp almost completely abolished promoter activity ( Fig. 1B and data not shown). Since a putative Sp1 binding site with the sequence GGGGTGG is located between bp -60 and -49, site-directed mutagenesis was performed changing the third or fourth G to T (G3mut and G4mut): either mutation almost completely suppressed transient luc activity in transfected HeLa cells (Fig. 1B) . As a confirmation for the key role of these two G residues, the 5′ deletion with end point GGGTGG (-55) had a similar transient expression as the wild-type HEFT1-luc, while that leaving only TGG (-52) had lost most of its activity.
To identify proteins interacting with this element, EMSA was performed with nuclear extract from HeLa cells and a 32 Plabelled oligonucleotide extending from coordinates -60 to -36 bp. Three specific protein-DNA complexes (C1, C2 and C3 in Fig. 1C ) were observed that were challenged with antibodies directed against HLTF or the Sp1 and Sp3 transcription factors, known to specifically interact with such GC boxes (19) . Formation of the C3 complex was suppressed by addition of anti-HLTF antibodies (lane 2). Addition of anti-Sp3 antibodies to the EMSA reaction abolished complex C2 (lane 9). A partial supershift (S) of complex C1 was caused by anti-Sp1 antibodies (lane 8) and further addition of anti-Sp3 antibodies suppressed most of the remaining complex (lane 10). Formation of the HLTF-DNA complex was increased by antibody titration of Sp1 and Sp3 (C3 in lanes 8-10 versus 7). When EMSA was performed with oligonucleotides bearing the G3 or G4 mutation (G3mut and G4mut, sequences given in Table 2 ) Sp1/Sp3 binding was nearly abolished (C1 and C2, lanes 3-6). However, HLTF could still bind to the oligonucleotide bearing the G3 mutation (C3 in lane The primer extension products were analysed on an 8% sequencing gel followed by autoradiography. The markers are sequencing reactions generated with the same primer on the HEFT1-luc template (lanes T, G, C and A).
3, suppressed by anti-HLTF antibody in lane 4), suggesting that it did not play a role in basal HEFT1 expression.
Finally, the ability of Sp1/Sp3 to activate the minimal HEFT1 promoter fused to a lacZ reporter gene was evaluated by co-transfection in Drosophila melanogaster SL2 cells, which do not contain endogenous Sp factors. A 4-to 6-fold increase in β-galactosidase activity was observed on co-transfection of SL2 cells with HEFT1-lacZ and either the pPacUbxSp1 or pPacUbxSp3 expression vectors, as compared with the level obtained with the promoterless reporter vector (Fig. 1D , lanes 2 and 3 versus lane 1). A similar result was obtained with the -60 HEFT1-lacZ vector (lanes [4] [5] [6] . When the HEFT1 point mutations which prevented Sp1/Sp3 binding in vitro were introduced into this construct, only a residual activation by either transcription factor was found (lanes 7-12). Expression of Sp1 and Sp3 in these experiments and their ability to specifically interact with the HEFT1 GC box were confirmed by EMSA (data not shown).
In aggregate, these data demonstrate that basal expression of the HEFT1 promoter is mediated by a GC box interacting with Sp1 and Sp3 and that mutation of G3 or G4 in this element abolishes promoter activity by suppression of Sp1/Sp3 binding.
Cloning of a HEFT1-related cDNA
Two northern blots with poly(A) RNA from different human tissues were hybridized to an antisense RNA probe extending from coordinates +25 to +62 bp of the HEFT1 genomic fragment. Autoradiography revealed four mRNA species (4.4, 3.0, 2.3 and 1.4 kb) at various abundances in several tissues (Fig. 3A and B) , with the strongest signals in testis, liver, uterus, heart and skeletal muscle. The probe was stripped and the northern blot of Figure  3B re-hybridized with a PCR-generated probe covering the first homeobox of a 3.3 kb repeat from the FSHD locus (coordinates 1768-2156 bp in HSFSHD). A 4.4 kb mRNA was observed in all tissues, but at a much higher abundance in skeletal muscle and heart, together with a smear extending up to 3 kb (Fig. 3C) .
Since 4.4 kb mRNA species were observed in heart and skeletal muscle with the two probes, we assumed that a HEFT1-like mRNA could be homologous to the 3.3 kb repeats. Therefore, in order to identify such a transcript, two primers were designed for RT-PCR with total RNA from human rhabdomyosarcoma TE671 cells. The upstream primer mapped just 3′ from the HEFT1 transcription start site experimentally determined above (coordinates +2 to +22 bp in Fig. 1A ), while the downstream primer was a sequence located 3′ of the homeoboxes in a 3.3 kb repeat from the FSHD locus (HSFSHD; Table 2 ). A single RT-PCR band of the expected size (1.25 kb) was obtained, the DNA subcloned and 19 clones randomly picked for sequence determination: four of these were identical, matching with the known transcribed region of HEFT1 (coordinates +23 to +63 bp in Fig. 1A and 22 to 62 bp in Fig. 4A ), except for the absence of a T located at bp +24 in the genomic sequence. The nucleotide sequence of this cDNA was entirely determined and found to contain a translation start codon and a 170 amino acid ORF covering a double homeobox ( Fig. 4A ): the cDNA was thus named DUX1 for double homeobox. Other RT-PCR experiments performed with the same 5′ primer and a 3′ primer located in the middle of the second homeobox on mRNAs extracted from normal human skeletal muscle or hepatoma HepG2 cells yielded 25 additional fragments. Three of these were identical and presented 98% identity to the DUX1 cDNA; interestingly, none of the mismatches affected the ORF (data not shown).
Amino acid sequence similarities to the consensus homeodomain derived from the dispersed superclass (20) are 49 and 54% for the first and second DUX1 homeodomains, respectively, and sequence alignment demonstrates conservation of the key residues ( Fig. 4B) , suggesting that the three typical α-helices could form in both domains. The highest similarity was found with paired-type homeodomains, as previously shown for the homologous double homeodomains putatively encoded by the FSHD locus repeats (5, 6) . The first DUX1 homeodomain is more closely related to those of human PAX3 and PAX7 and to D.melanogaster Paired (Fig. 4C) . The second DUX1 homeodomain is more similar to those of human OTX1 and OTX2 and to chicken Pax6 (Fig. 4D) . The homology to the paired-type homeodomain does not, however, extend to the characteristic serine residue at position 50, which is replaced by a glutamine (Q* in Fig. 4 ) in both DUX1 homeodomains. Both predicted DUX1 homeodomains presented a glutamine (Q* in Fig. 4 ) in the ninth position of helix 3, which was shown for paired-type homeodomains to target specific DNA binding to oligonucleotides with a 3-5 bp spacing between the two halves of the TAAT/ATTA palindrome (21) . When either of these 32 P-labelled P3 or P5 oligonucleotides (sequences in Table 2 ) was incubated with reticulocyte lysate programmed with the control luciferase cDNA, a C1 complex was formed in EMSA (Fig. 5B , Table II ). The two protein-DNA complexes (C1 and C2) and free DNA (F) are indicated. (C) EMSA was performed with 1 µl TNT reticulocyte lysate programmed with DUX1 cDNA and 32 P-labelled P5 oligonucleotide. Competition with increasing amounts (50 or 100-fold molar excess) of P3 (lanes 3 and 4), P5 (lanes 5 and 6) or unrelated B box (lanes 7 and 8) oligonucleotide was as indicated (sequences provided in Table 2 ). The two protein-DNA complexes (C1 and C2) and free DNA (F) are indicated. lanes 3, 4, 7 and 8). The in vitro transcription/translation products of the DUX1 cDNA formed an additional complex with the P5 oligonucleotide only (complex C2, lanes 1 and 2 versus 5 and 6). Competition with a 50-fold molar excess of P5 abolished C2 complex formation (Fig. 5C , lane 5), while up to a 100-fold excess of P3 did not completely suppress the C2 complex (lanes 3 and 4): no effect was observed with a similar excess of an unrelated oligonucleotide [B box from the PAI-1 promoter (22)] (lanes 7 and 8).
One copy of the P5 oligonucleotide was fused to a luc reporter gene with a minimal adenovirus major late promoter and the resulting P5-AdMLp-luc vector introduced into SL2 insect cells. Co-transfection with different amounts of a DUX1 expression vector driven by the CMV promoter/enhancer (pCI-DUX1) yielded a dose-dependent increase in luciferase activity between 62 and 250 ng, followed by a sharp decrease at higher concentrations (Fig. 6A ). This decrease was not due to cell toxicity, as judged from β-galactosidase expression driven by the co-transfected internal control pCMVβ (data not shown). At the optimal dose of the DUX1 expression vector, a 4-to 5-fold increase in P5-AdMLp-luc basal expression was observed. Expression of a similar reporter vector (P3-AdMLp-luc) made with the P3 oligonucleotide, which does not interact with the DUX1 homeoprotein in vitro, was not affected by co-transfection with pCI-DUX1 nor with the parental control vector (Fig. 6B) .
In conclusion, the DUX1 homeoprotein activates transcription from a promoter containing the P5 oligonucleotide onto which it specifically binds in vitro.
Identification of the DUX1 protein in vivo
A peptide (amino acids L4-R21 in Fig. 4A ) located in the N-terminal region of DUX1 and extending by 3 amino acids into the first homeodomain was selected to raise a specific rabbit antiserum (see Materials and Methods). This antiserum was tested on a western blot with in vitro translated DUX1, revealing a single band of the expected 20 kDa size that was not present when wheat germ extract was programmed with the control luciferase cDNA (Fig. 7A, lane 2 versus 1) . The antiserum specificity was confirmed by titration with the peptide against which it had been raised (lanes 3 and 4) . In order to demonstrate the presence of DUX1 in vivo, TE671 rhabdomyosarcoma 1 and 3) or DUX1 (lanes 2 and 4) cDNA were analysed by SDS-PAGE followed by western blotting with a rabbit antiserum raised against a peptide from the DUX1 sequence (amino acids 4-21) in the absence (lanes 1 and 2) or presence (lanes 3 and 4) of the peptide (100 mg/ml). (B) Aliquots of 100 µg protein of TE671 whole cell extract were analysed by SDS-PAGE and western blotting with either rabbit pre-immune serum (lane 1) or the anti-DUX1 peptide serum described in (A) (lanes 2 and 3) in the absence (lanes 1 and 2) or presence (lane 3) of the peptide. (C) Aliquots of 100 µg protein of TE671 whole cell extract were analysed by SDS-PAGE and southwestern blotting in the presence of 20 ng 32 P-labelled P5 oligonucleotide (specific activity 2 × 10 8 c.p.m./µg; sequence provided in Table II) extracts were analysed by SDS-PAGE followed by western blotting with this antiserum: 50 and 20 kDa proteins were revealed that were not observed with pre-immune serum nor on titration with the DUX1 peptide (Fig. 7B, lane 2 versus lanes 1  and 3) .When the western blot was probed with the 32 P-labelled P5 oligonucleotide that selectively interacts with DUX1 in EMSA (Fig. 5 ) four proteins were identified, one of which presented a 20 kDa apparent molecular weight (Fig. 7C) .
DNA binding and immunoreactivity of this putative DUX1 protein were then simultaneously investigated by EMSA: rhabdomyosarcoma extracts were incubated with the 32 P-labelled P5 oligonucleotide, yielding several protein-DNA complexes, one of which had identical migration to the P5-DUX1 complex observed with in vitro translated DUX1 (Fig. 7D , lane 3 versus lane 2). This complex was specific, since it was competed out by a 50-fold molar excess of P5 and diminished by addition of P3, but not affected by an unrelated oligonucleotide (data not shown). Moreover, this complex disappeared on addition of the anti-DUX1 peptide antiserum (Fig. 7D, lane 4) . Two slower migrating complexes were also suppressed on antiserum addition and might involve DUX1.
In aggregate, these data indicate that a protein with the DNA-binding properties, apparent molecular weight and immunoreactivity of in vitro translated DUX1 is present in TE671 rhabdomyosarcoma nuclear extracts. The DUX1 loci mapped to chromosomes 13, 14, 15, 21 and 22 (see Materials and Methods), as was found for HEFT1. Members of the 3.3 kb repeat family are intronless and it was thus expected that a 800 bp fragment could be amplified by PCR on genomic DNA with primers located 5′ within the HEFT1 promoter and 3′ within the DUX1 structural part (primers HD001 and SP158 in Table 2 ). However, this experiment failed, demonstrating that HEFT1 and DUX1, which differ in their overlapping region by a single nucleotide (T) deletion, do not derive from the same 3.3 kb element. Attempts at identifying the HEFT1 structural part in this way with the same 5′ primer and a primer located at the 5′-end of the second homeobox (SP172), in a region conserved among 3.3 kb family members, yielded the expected 600 bp band: further analysis identified six different sequences in these amplified fragments. One of these was identical to HEFT1, except for a C/T mismatch at bp +38, and contained a structural part with 86% nucleotide sequence identity to DUX1; its ORF started in the same position as DUX1 but stopped just after the first homeodomain (80 amino acids) and was 70% identical at the amino acid level. This gene was named DUX2 and it was also mapped to all the acrocentric chromosomes (see Materials and Methods). A 90 bp RT-PCR product identical to a part of its sequence could be derived from HeLa cells (data not shown).
In conclusion, although the HEFT1 and DUX1 regions are not associated in the genome, another 3.3 kb element (DUX2) was found carrying a promoter identical to HEFT1 fused to a DUX1-like structural part that seems to be transcribed in HeLa cells.
DISCUSSION
HEFT1 promoter activity
The initial purpose of this study was to identify genes regulated by HLTF. Indeed, this SNF/SWI family member has a specific DNA-binding domain recognizing a rather degenerate target. Among the 60 cloned immunoprecipitated chromatin fragments, there was a strong enrichment for repetitive elements such as Alu sequences, α-satellites and LINEs: a role HLTF might have in relation to these elements is unclear at the present time.
The promoter identified in the immunoprecipitated HEFT1 fragment contains two binding sites for HLTF as determined by EMSA. One of these sites is located on the GC box mediating basal expression: such an overlap between Sp1 and HLTF binding sites has also been found in the B box of the PAI-1 promoter (22) . A PAI-1 B box mutation that inhibited HLTF binding suppressed basal expression (12) ; it was recently found to also affect Sp1/Sp3 binding (H. Ding, unpublished data). In the HEFT1 promoter, the mutations that affected basal transient expression prevented binding in vitro of Sp1/Sp3: only one of them (G4mut) also inhibited HLTF binding. Attempts at co-transfection of a HEFT1-lacZ reporter construct with an expression vector for HLTF yielded only minor activation in insect cells (data not shown). Similarly, the HEFT1-lacZ activation observed in the presence of Sp1/Sp3 expression was not affected by co-expression of HLTF (data not shown). However, since HLTF belongs to the SNF/SWI family of proteins known to modulate chromatin structure (reviewed in refs 23, 24) , it is conceivable that such a role could not be identified in transient expression experiments but would require the use of reporter constructs stably integrated into the cell genome.
The 4-to 5-fold activation by Sp3 as well as Sp1 observed for the HEFT1 promoter is in contrast to the observations made on promoters containing several GC boxes that are not activated by Sp3 and for which an inhibitory effect of Sp3 on Sp1-mediated trans-activation was demonstrated (25) . A similar activation by Sp3 was observed on the TGFβ promoter, which contains a single GC box (26) . Contradictory data have been published on the role of Sp3 on the c-myc promoter, which contains a single GC box, as does the HEFT1 promoter (25) (26) (27) . The delineation of a small inhibitory domain in Sp3 that silences its two activation domains suggests that modulation of Sp3 transcriptional activity could occur in vivo, probably explaining the discrepancy between those results (28) .
mRNAs homologous to HEFT1
The HEFT1 transcription initiation site was mapped 63 bp upstream from the 3′-end of the 182 bp fragment by analysis of the luciferase fusion mRNA expressed in cells transfected with the HEFT1-luc construct. Hybridization of this short known transcribed region to a northern blot identified several mRNAs, some of which also hybridized with a D4Z4 homeobox probe. Although the conditions used for these experiments were very stringent, they did not provide specificity for a single 3.3 kb element and caution should be exerted in interpreting those data in terms of mRNA abundance. mRNAs with sizes ranging from 1.4 to 4.4 kb were observed in this experiment. How could such heterogeneous mRNAs arise from 3.3 kb repeats? For the shorter species, transcription termination signals could have appeared in different positions in HEFT1-like elements if they presented the sequence microheterogeneity observed for other members of the 3.3 kb family. For the longest mRNA, transcription could extend outside the HEFT1 element through 3′-flanking consecutive 3.3 kb repeats. Another possibility is that the HEFT1 element is contiguous with a large number of shorter tandem repeats (such as β-satellites) through which transcription could proceed: these can extend over several kilobases, as has been shown in the vicinity of other 3.3 kb family members (7).
The DUX1 protein
The 170 amino acids of the DUX1 protein just accommodate the two homeodomains with 15-20 amino acid spacing in the N-terminal, central and C-terminal flanking regions. The proteins to which it presents highest similarity (Fig. 4) are involved in development and their mutations are extremely deleterious. PAX3 and PAX7 are expressed during neural crest development and skeletal muscle differentiation and overexpression or fusion of either of them to the forkhead protein FKRH is associated with rhabdomyosarcoma (29) (30) (31) . PAX3 mutations have been linked to the hereditary Waardenburg syndrome characterized by hearing loss and pigmentary abnormalities and to its mouse equivalent, the splotch mutant (30) . The OTX1 and OTX2 proteins are related to Drosophila Orthodenticle and play a role in brain development, as shown in mice lacking those genes (32, 33) . In contrast, the PAX6 protein is a key regulator of eye development and is mutated in aniridia syndrome (34) .
The highest similarity observed between DUX1 and pairedtype homeodomains has suggested a target DNA based on the amino acid at position 9 of the third helix. Intriguingly, although the other paired-type homeodomains with a glutamine in this position bind equally well to oligonucleotides with a 3 or 5 bp spacing between the two halves of the ATTA/TAAT palindrome (21), the DUX1 protein binds strongly to the P5 oligonucleotide and only very weakly to the P3 one (Fig. 5) . The presence of two homeodomains in close proximity might bring steric hindrance to the interaction with DNA, requiring the larger spacing for complex formation. Since both homeodomains are well conserved and present the key glutamine in the recognition helix, they might both contribute to DNA binding. The presence of two DNA-binding domains in the same protein is frequent in the homeoproteins, but usually results from the addition of a different domain, such as a paired, cut or POU domain. To our knowledge, examples of multiple homeodomains are only provided in the zinc finger homeoprotein subclass, where up to 17 C2H2-type zinc fingers are associated with one to four homeodomains (20) .
Transcriptional activation by the DUX1 protein of the artificial construct made with the P5 oligonucleotide fused to a minimal promoter was strictly dose dependent, showing a bell-shaped curve between 62 and 1000 ng DUX1 expression vector, with a maximum at 250 ng. This progressive inactivation at such low concentrations of expression vector is in contrast to the continuous activation described for other paired-type homeoproteins in a similar insect cell co-transfection assay (21) . However, a similar behaviour was described for full-size Pax3 when expressed in NIH 3T3 cells with an artificial reporter construct similar to ours (35) . Investigations on whether this phenomenon is related to the artificial template used or shows a complex regulatory role of DUX1 will await identification of the natural homeoprotein targets.
Chromosome location of HEFT1, DUX1 and DUX2
The DUX1 cDNA initially considered to be derived from the HEFT1 promoter presents an identical sequence over their 40 bp overlap, except for the absence of a T located at bp +24 in the genomic DNA. Further studies demonstrated that the HEFT1 and DUX1 sequences were not linked in the genome. A DUX2 genomic fragment was cloned showing identity to the 182 bp HEFT1 promoter, except for a C/T mismatch at bp +38: this difference could either be a polymorphism (HEFT1 and DUX2 were derived from HeLa cells and from a normal individual, respectively) or result from cloning of two different 3.3 kb elements. The three cloned DNA fragments all map to chromosomes 13, 14, 15, 21 and 22, but it is not known yet on which arm. Other members of the 3.3 kb dispersed repeat family have indeed been found on the short arm of all the acrocentric chromosomes, in the heterochromatic regions adjacent to the ribosomal DNA gene clusters (7, 9) . Different members of the family might be present simultaneously, since co-localization of other types of repeated elements has already been shown. Two types of organization were described for the 3.3 kb family: either tandem arrangement with β-satellite sequences (68 bp Sau3A repeats) at the distal end, as in the FSHD locus, or clusters where 3.3 kb elements are interspersed with β-satellite repeats (9) or with other sequences such as rRNA genes and β-satellite repeats (7).
Similarity of HEFT1/DUX1 to known 3.3 kb repeats
Isolation of individual 3.3 kb elements has proved very difficult because of the high similarity between family members and, after extensive search for a HEFT1-structural gene, we cannot yet be sure that we have found it within DUX2, since one mismatch was found in this sequence as compared with HEFT1. However, since this difference does not affect the promoter features we identified, we can conclude that some 3.3 kb elements comprising simultaneously a promoter and an ORF for a homeoprotein do exist.
The HEFT1-homologous sequence hhspm3 (accession no. X06587) that was isolated because it is unmethylated in sperm and thus potentially expressed in spermatogenesis (16) has a putative promoter with the same key features as HEFT1 (TATAA and GC boxes): the fragment is, however, too short to investigate the presence of a putative ORF including the homeoboxes. Interestingly, high expression of HEFT1-like sequences was observed in testis mRNAs (Fig. 3A) .
Alignment of the HEFT1 promoter and 3.3 kb repeats from the FSHD locus identified in four of these (accession nos HSFSHD, L32607, U74497, U85056; Table 1 ) a conserved GC box and a TACAA sequence in the position homologous to the HEFT1 TATAA box. In another promoter context, such a mutation maintains a pyrimidine which interacts with Thr173 of the TATA-binding protein (36) and has been shown to reduce to 16% the level of in vitro transcription in HeLa cell extracts (37) . The third FSHD repeat sequence known (accession no. U18977) presents a CATAA sequence and no conserved GC box: our data on the homologous HEFT1 promoter suggest that it would be inactive. The 3.3 kb-like cDNA sequences JH and δ4 (accession nos L32605 and L32606) contain regions homologous to the HEFT1 promoter; since they were derived from transcribed sequences, they had to originate from another promoter located further upstream. Indeed, if they have a conserved HEFT1 TATAA box, they present the G4 mutation which was shown in the present study to suppress basal expression from the HEFT1 promoter.
In aggregate, these data suggest that a promoter might be present in some of the FSHD locus 3.3 kb repeats: in three of the sequences known (Table 1) , this TACAA box is located 150 bp upstream from an ATG initiating an ORF that includes the two homeoboxes recently shown to be conserved at the ancestral 4q35 locus in primates (7) . Figure 8 presents schematically one example of part of a D4Z4 repeat (HSFSHD) aligned with the fragments cloned in the present study. The beginning of the Figure 8 . Putative promoter and ORF in a 3.3 kb element from the D4Z4 locus. Schematic representation of the fragments homologous to 3.3 kb repeated elements cloned in this study (DUX1 cDNA, HEFT1 promoter and DUX2 genomic fragment) and their alignment with a representative D4Z4 element (HSFSHD; see Table 1 ). The promoter (GC and TATAA or TACAA boxes) and ORF (ATG and translation STOP) features are indicated. The homeoboxes are striped and the experimentally determined transcription initiation site (Fig. 2) is shown by an arrow. The end of the HSFSHD ORF has not been indicated because of several discrepancies among sequences derived from D4Z4 in that very GC-rich region.
putatively encoded protein presents high similarity to DUX1, suggesting a similar transcriptional function if the protein was expressed. Alterations in its expression consecutive to chromosome deletion in 4q35 could explain a pleiotropic phenotype such as that characterizing FSHD. However, the high GC content of the FSHD locus and cytogenetic data have suggested that it was packed as heterochromatin and transcriptionally inactive: indeed, many attempts from different laboratories at isolating cDNAs of mRNAs derived from the locus have failed (5, 7, 9) . In our quest for the HEFT1 RNA, ∼50 3.3 kb-like RT-PCR fragments have been sequenced, none of them presenting >90% identity with the FSHD repeats (data not shown).
In conclusion, although the HEFT1 and DUX fragments investigated in this study clearly do not map to the FSHD locus, sequence homology with D4Z4 elements raises the intriguing possibility that some of these might express a DUX1-like protein.
Our observations thus bring a renewed interest in the search for transcripts derived from the FSHD locus.
MATERIALS AND METHODS
Materials
Genomic DNA of the National Institute of General Medical Sciences Mapping Panel 2 was obtained from Coriell Cell Repository (Camden, NJ). The pGL3-Promoter, pGL3-Basic and pCI-neo vectors, luciferin, reporter lysis buffer, TNT reticulocyte lysate and wheat germ extract, Riboprobe in vitro transcription and AMV primer extension systems were from Promega (Leiden, The Netherlands). The Galacto-Light kit was from Tropix (Bedford, MA). The pCR2.1 vector and TA cloning kit were from Invitrogen (San Diego, CA), Nonidet P40 from Sigma (St Louis, MO) and phenylmethylsulfonyl fluoride (PMSF) from Fluka (Bornem, Belgium). Protein A-Sepharose, QuickPrep mRNA extraction kit, AutoRead Sequencing kit, fluorescence labelled dATP, pUC18, pGEM4Z and poly(dI·dC)·poly(dI·dC) were from Pharmacia Biotech (Brussels, Belgium). Radioactive precursors and the Enhanced Chemiluminescence (ECL) western blot detection kit were from Amersham (Ghent, Belgium) and autoradiography enhancer EN3HANCE from Du Pont-NEN (Albany, MA). Culture media, fetal calf serum and media additions, OptiMEM, lipofectamine transfection reagent, 1 kb DNA molecular weight markers and high efficiency Escherichia coli DH5α competent cells were from Gibco BRL (Ghent, Belgium). Falcon culture dishes were from Becton Dickinson (Lincoln Park, NJ). The Qiagen plasmid extraction kits were from Westburg (Leusden, The Netherlands). Human multiple tissue northern blots, ExpressHyb solution, poly(A) RNA from normal human skeletal muscles, the pCMVβ vector and the Advantage KlenTaq polymerase mix were from Clontech (Palo Alto, CA). Oligonucleotides, DUX1 peptide, rabbit pre-immune and antipeptide antiserum were from Eurogentec (Seraing, Belgium). Monoclonal antibodies against Sp1 and Sp3 were from Santa Cruz Biotechnology (Santa Cruz, CA) and the goat anti-rabbit immunoglobulin serum from Bio-Rad (Hercules, CA); the monoclonal antibody directed against PAI-1 was described previously (38) . The human β-actin cDNA in pSPT18 (in the RNase protection kit) and Taq polymerase were from Boehringer Mannheim (Brussels, Belgium). GST-6D3, a fusion protein between glutathione S-transferase and the HLTF DNA-binding domain, and mAb 2F6, a monoclonal antibody directed against 6D3, have been described previously (12) . The HeLa and TE671 cell lines were provided by Dr C. Backendorf (Laboratory of Molecular Genetics, University of Leiden, Leiden, The Netherlands) and Dr P. Munoz-Canova (Institut de Recerca Oncologica, Barcelona, Spain), respectively. Drosophila melanogaster 
Immunoprecipitation of HLTF-DNA complexes
The procedure was essentially as previously described (15) . A total of 10 10 HeLa cells were harvested and washed once with ice-cold phosphate-buffered saline (PBS). Isolated nuclei were digested with HaeIII and the released chromatin fragments were treated with 20 µg/ml monoclonal antibodies against human PAI-1 (38) and 30 µl protein A-Sepharose for 1 h at 4_C. The cleared supernatant was then incubated with 20 µg/ml mAb 2F6 for 2 h and with 30 µl protein A-Sepharose for 1 h at 4_C. The immunoprecipitates were washed with PBS and extracted with phenol/chloroform. The extracted genomic DNA fragments were subcloned into the SmaI site of pUC18.
Chromosome mapping of HEFT1, DUX1 and DUX2 loci
Genomic DNA from a panel of hamster/human cell hybrids was used for PCR amplifications with 'specific' (i.e. presenting at least two mismatches with sequences of other family members available in the EMBL/GenBank database; Table 1) primers followed by Southern blotting and hybridization with internal primers defined similarly (primers are given in Table 2 ). For HEFT1, amplification was performed with primers HD001 and HD002, KlenTaq enzyme and 'touchdown' PCR (17) at 95_C for 3 min, five cycles of 96_C for 10 s, 65_C for 30 s and, finally, 30 cycles of 96_C for 10 s, 63 _C for 30 s. For DUX1, a semi-nested PCR was performed with primers SP157 and SP158 on the product of a PCR with primers SP168 and SP158 under standard PCR conditions (35 cycles of 94_C for 30 s, 57_C for 30 s, 72_C for 1 min). For DUX2, the primers MCB2 and MCB5 were used under the same conditions. Hybridization was performed with primer HD006 for HEFT1 and MCB3 for DUX2. The primers were end-labelled with T4 polynucleotide kinase and [γ-32 P]ATP to a specific activity of 2 × 10 8 c.p.m./µg and hybridization conditions were 6× SSPE, 5× Denhardt's, 0.5% SDS and 200 µg/ml heparin at 65_C. Final washing was carried out in 2× SSPE, 0.1% SDS at 68_C.
EMSA
The genomic DNA fragments subcloned in pUC18 were labelled with [α-32 P]dCTP by one PCR cycle with Taq polymerase using 100 ng universal and reverse primers as described (39) . Synthetic oligonucleotides (Table 2) were end-labelled with [γ-32 P]ATP and T4 polynucleotide kinase. EMSAs for binding of HLTF and Sp1/Sp3 were performed with either 10 ng GST-6D3, 10 µg HeLa cell nuclear or TE671 whole cell extract or 1-2 µl reticulocyte lysate or wheat germ extract incubated with 20 000 c.p.m. 32 P-labelled probe in a 20 µl volume containing 1 µg poly(dI·dC)·poly(dI·dC) in 10 mM Tris-HCl buffer, pH 8.0, with 100 mM KCl, 12% glycerol, 0.5 mM EDTA, 1 mM dithiothreitol (DTT). After 15 min at room temperature, electrophoresis was performed at 4_C on a 4% polyacrylamide gel in 0.5× Tris-borate buffer, pH 8.5, which was pre-run for 30 min. When needed, 1 µl antibody (corresponding to 100 ng protein) was added to the binding assay mixtures and incubated for 30 min on ice before addition of labelled probes.
EMSA for DUX1 binding was carried out in a 20 µl volume containing 1 µg poly(dI·dC)·poly(dI·dC) in 15 mM Tris-HCl buffer, pH 7.5, with 60 mM KCl, 0.5 mM DTT, 0.05% NP-40, 7.5% glycerol as described for paired-type homeodomains (21) .
Plasmid constructs
The 182 bp HEFT1 genomic fragment and its different deletion or point mutants (Fig. 1) were obtained by PCR amplification using sets of 5′ and 3′ oligonucleotide primers containing a BglII and a HindIII site, respectively. The PCR products were cloned into the BglII and HindIII sites of the pGL-3-Basic plasmid, yielding the HEFT1-luc series. For transfection experiments in D.melanogaster SL2 cells, the test DNA fragments were subcloned into the BamHI and HindIII sites of the ∆44-lacZ vector (40) , replacing the original alkaline phosphatase promoter, to yield the HEFT1-lacZ series.
For co-transfection experiments, a DUX1 cDNA fragment (bp 104-1226) was amplified by PCR (primers given in Table 2 ) and inserted into the EcoRI site of the pCI-neo vector under control of both the CMV and T7 promoters, yielding pCI-DUX1. The minimal (-34 to +33 bp) adenovirus major late promoter (AdMLp) was cloned as a BglII/HindIII fragment upstream of the luc gene into the pGL3 vector. One copy of either the P3 or the P5 oligonucleotide (Table 2 ) synthesized with BglII linkers was then inserted into the BglII site to provide the P3-AdMLp-luc and P5-AdMLp-luc reporter constructs, respectively.
All the constructs were confirmed by nucleotide sequence determination and purified with Qiagen plasmid extraction kits.
Cell cultures and transfections
HeLa and TE671 cells were grown in DMEM F12 or DMEM, respectively. All media were supplemented with 1 mM glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 10% heat-inactivated fetal calf serum. A total of 2.5 × 10 5 HeLa cells and 1.5 × 10 5 TE671 cells were seeded per well in Falcon 6-well plates and grown overnight. For transfection, 2 µg reporter plasmid, 10 ng pCMVβ internal control and 8 µl lipofectamine in 1 ml OptiMEM medium were added to each well. After 5 h, the cells were washed with PBS and supplemented with growth medium. Cells were harvested for luciferase and β-galactosidase assays 16 h after transfection (see below). Luciferase activities were normalized to β-galactosidase activities.
Drosophila melanogaster SL2 cells were grown at 28_C in M3 medium supplemented as above. One day prior to transfection, cells were plated into 3.5 cm dishes at a density of 2.5 × 10 6 per dish. Cells were transfected by the calcium phosphate co-precipitation method as described (41) . Each dish received 4 µg reporter plasmids and 1 µg expression plasmid, using cDNA-less expression plasmids as controls. After DNA addition, the plates were left undisturbed until time of harvest, 24 h later.
Reporter activities were determined for mammalian and insect cells as follows: 250 µl Promega lysis buffer was added directly to the cells in each well, protein concentration was determined with the Bradford assay (42) and equal amounts of cell extracts were used for assay of luciferase with luciferin and β-galactosidase with Galacton chemiluminescent substrate according to the manufacturers' instructions. Transfections were done in triplicate and repeated three to five times with different preparations of the same plasmid.
RNA analyses
Sixteen hours after transfection with HEFT1-luc (see above), 1.7 × 10 6 HeLa cells were harvested and the mRNAs isolated with the QuickPrep mRNA purification kit. For primer extension, 1 µg poly(A) mRNA was reverse transcribed with AMV reverse transcriptase using an oligonucleotide primer located at the 5′-end of the luc gene (primer given in Table 2 ). Reaction products were resolved on 6% polyacrylamide-8 M urea gels and exposed to autoradiography for 2 days; the markers were sequencing ladders generated by the dideoxy chain termination method with the same primer on the HEFT1-luc template.
Multiple human tissue northern blots were hybridized with an antisense RNA probe which covered coordinates +25 to +62 bp of HEFT1 (Fig. 1A) .The riboprobe was generated by in vitro transcription by T7 RNA polymerase in the presence of [α-32 P]UTP from a HEFT1 subclone in pGEM4Z. The blot was pre-hybridized for 15 min in 50% formamide, 6× SSPE, 5× Denhardt's solution, 0.5% SDS and 100 µg/ml salmon sperm DNA and hybridized in the same medium containing 2 × 10 6 c.p.m./ml probe for 20 h at 50_C. The blot was washed at increasing stringency, with the last wash in 0.1× SSC, 0.5% SDS at 76_C for 30 min, and exposed to autoradiography for 2 days at -70_C with intensifying screens. As a control, an antisense human actin cDNA probe was used. The RNA probe was stripped by treatment in boiling 0.1× SSPE and probe removal confirmed by autoradiography. One northern blot was re-hybridized with a homeobox DNA probe generated from XPst9 by PCR with Taq polymerase in the presence of [α-32 P]dCTP with primers designed on the FSHD locus repeat sequence HSFSHD (6) (primers are given in Table 2 ). Hybridization was performed in ExpressHyb solution containing 2 × 10 6 c.p.m./ml probe according to the manufacturer and the last wash was in 0.1× SSC, 0.1% SDS at 80_C for 40 min. Autoradiography was performed as described above.
Reverse transcription followed by PCR amplification (RT-PCR) was performed on RNA extracted as above from TE671 cells and on poly(A) RNA from normal human skeletal muscles. The 5′ primer was located at coordinates + 2 to + 22 bp within HEFT1 and the 3′ primer was derived from the FSHD repeat sequence HSFSHD (6) (primers are given in Table 2 ). Amplification was with KlenTaq enzyme and 'touchdown' PCR (17) at 95_C for 1 min, 5 cycles of 96_C for 10 s, 72_C for 1.5 min and 30 cycles of 96_C for 10 s, 70_C for 1.5 min. The resulting fragments were cloned in the pCR2.1 vector. No amplification was observed when the RT step was omitted.
Protein analysis
Extracts of TE671, HeLa and SL2 cells were prepared as previously described (43) . Briefly, for a nuclear extract, the nuclei were resuspended in 5 mM HEPES buffer, pH 7.9, containing 25% glycerol, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF and NaCl was added to 300 mM. After incubation for 30 min on ice and centrifugation, the supernatant was frozen in aliquots. Whole cell extracts were obtained by freeze-thawing cells in 20 mM HEPES buffer, pH 7.8, containing 25% glycerol, 0.4 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, and 450 mM NaCl. 35 S-labelled in vitro translation products were analysed by electrophoresis on 12% polyacrylamide gels (SDS-PAGE): the gels were treated with EN3HANCE and dried for fluorography.
For western blotting, the SDS-PAGE gel was transferred to a nitrocellulose membrane that was then blocked with 5% defatted milk, incubated with rabbit antiserum raised against a DUX1 peptide (amino acids 4-21 with an additional Cys to allow coupling to keyhole limpet haemocyanin for immunization) in the presence or absence of a 400 molar excess of the peptide and revealed with goat anti-rabbit immunoglobulin serum and the ECL system according to the manufacturer. For southwestern blotting (44) the nitrocellulose membrane was incubated overnight at 4_C with 25 mM HEPES buffer, pH 8.0, containing 2.5% defatted milk, 1 mM DTT, 10% glycerol, 50 mM NaCl, 0.05% Nonidet P40 and 1 mM EDTA. Then the blot was incubated with 10 µg/ml poly(dI·dC)·poly(dI·dC) and 2 × 10 6 c.p.m./ml 32 P-endlabelled DNA probe (sp. act. 2 × 10 8 c.p.m./µg) in 10 mM Tris-HCl buffer, pH 7.5, containing 50 mM NaCl, 1 mM EDTA and 1 mM DTT for 2 h at room temperature. After a wash in the same buffer, autoradiography was performed.
Statistical analysis
Student's t-test for paired values was used to evaluate luciferase and β-galactosidase transient expression.
DNA analysis
The DNA dideoxynucleotide sequencing reaction was performed with the AutoRead sequencing kit in the presence of either fluorescence labelled or unlabelled primers combined with fluorescence labelled dATP. Samples were analysed by electrophoresis on a 6% polyacrylamide-8 M urea gel (0.6× TBE) using the Automated Laser Fluorescent DNA Sequencer system from Pharmacia Biotech. Generated sequences were analysed with software (45) from the University of Wisconsin Genetics Computer Group provided by the Belgian EMBL node (Brussels, Belgium) and putative transcription factor binding sites searched with MatInd and MatInspector (18) . The sequences determined in this study have been deposited in the GenBank/EMBL Nucleotide Sequence Database under accession nos AJ001636 (HEFT1), AJ001481 (DUX1) and AF068744 (DUX2).
